{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:58:59Z","timestamp":1793465939675,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bcp.2025.117662","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T16:07:37Z","timestamp":1766246857000},"page":"117662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Eicosanoids and Inflammation: A delicate balance of Pro-Inflammatory and Pro-Resolving mediators"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4341-5188","authenticated-orcid":false,"given":"Woo Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117662_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115764","article-title":"Biochemical aspects of the inflammatory process: a narrative review","volume":"168","author":"Soares","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"18","key":"10.1016\/j.bcp.2025.117662_b0010","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.3390\/ijms231810719","article-title":"Involvement of Inflammation and its Resolution in Disease and Therapeutics","volume":"23","author":"Alfaro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117662_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107670","article-title":"Carcinogenesis: failure of resolution of inflammation?","volume":"218","author":"Fishbein","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117662_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177924","article-title":"Reprogramming inflammation: Mechanisms and therapeutic targeting of eicosanoids and pro-resolving mediators","volume":"1003","author":"Kolawole","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117662_b0025","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/biom11121873","article-title":"Essential Fatty Acids and their Metabolites in the Pathobiology of Inflammation and its Resolution","volume":"11","author":"Das","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2025.117662_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105663","article-title":"Inflammation: Biochemistry, cellular targets, anti-inflammatory agents and challenges with special emphasis on cyclooxygenase-2","volume":"121","author":"Kaur","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"21","key":"10.1016\/j.bcp.2025.117662_b0035","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1111\/bph.15206","article-title":"Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19","volume":"177","author":"Robb","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117662_b0040","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400619R","article-title":"Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation","volume":"38","author":"Serhan","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2025.117662_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580117","article-title":"Non-inflammatory Physiology of \u201cInflammatory\u201d Mediators - Unalamation, a New Paradigm","volume":"11","author":"Maddipati","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117662_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106726","article-title":"Formation of lipoxins and resolvins in human leukocytes","volume":"166","author":"Kahnt","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bcp.2025.117662_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116089","article-title":"Resolution of inflammation: intervention strategies and future applications","volume":"449","author":"Panezai","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117662_b0060","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/biom10101402","article-title":"cPLA2\u03b1 Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation","volume":"10","author":"Ashcroft","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2025.117662_b0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biochi.2020.08.015","article-title":"Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake","volume":"178","author":"Calder","year":"2020","journal-title":"Biochimie"},{"issue":"11","key":"10.1016\/j.bcp.2025.117662_b0070","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/jnr.24934","article-title":"Is cyclooxygenase-1 involved in neuroinflammation?","volume":"99","author":"Ghazanfari","year":"2021","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.117662_b0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/1940-6207.CAPR-22-0038","article-title":"Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer","volume":"15","author":"Wilson","year":"2022","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.bcp.2025.117662_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714042","article-title":"Prostanoids and Resolution of Inflammation - beyond the Lipid-Mediator Class Switch","volume":"12","author":"Schmid","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117662_b0085","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.3390\/ijms24119647","article-title":"Pro- and Anti-Inflammatory Prostaglandins and Cytokines in Humans: a Mini Review","volume":"24","author":"Wautier","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117662_b0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-pharmtox-051921-085014","article-title":"Structures of Leukotriene Biosynthetic Enzymes and Development of New Therapeutics","volume":"63","author":"Haeggstr\u00f6m","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117662_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105561","article-title":"Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation","volume":"300","author":"Ermis","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117662_b0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-pathmechdis-111523-023509","article-title":"Cysteinyl Leukotrienes in Allergic Inflammation","volume":"20","author":"Lee","year":"2025","journal-title":"Annu. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117662_b0105","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaci.2021.08.015","article-title":"Eicosanoid dysregulation and type 2 inflammation in AERD","volume":"148","author":"Mullol","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"17","key":"10.1016\/j.bcp.2025.117662_b0110","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.81.17.5335","article-title":"Lipoxins: novel series of biologically active compounds derived from arachidonic acid in human leukocytes","volume":"81","author":"Serhan","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bcp.2025.117662_b0115","first-page":"308","article-title":"Mammalian lipoxygenases and their biological relevance. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of","volume":"1851","author":"K\u00fchn","year":"2015","journal-title":"Lipids"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117662_b0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/03602532.2022.2162075","article-title":"Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy","volume":"55","author":"ElKhatib","year":"2023","journal-title":"Drug Metab. Rev."},{"issue":"12","key":"10.1016\/j.bcp.2025.117662_b0125","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.3390\/molecules27123873","article-title":"CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators","volume":"27","author":"Shi","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bcp.2025.117662_b0130","doi-asserted-by":"crossref","first-page":"F138","DOI":"10.1152\/ajprenal.00052.2022","article-title":"Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy","volume":"324","author":"Noh","year":"2023","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"7","key":"10.1016\/j.bcp.2025.117662_b0135","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/bph.15726","article-title":"20-hydroxyeicosatetraenoic acid (20-HETE) is a pivotal endogenous ligand for TRPV1-mediated neurogenic inflammation in the skin","volume":"179","author":"Hamers","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"47","key":"10.1016\/j.bcp.2025.117662_b0140","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1265-24.2024","article-title":"The Nociceptor Primary Cilium Contributes to Mechanical Nociceptive Threshold and Inflammatory and Neuropathic Pain","volume":"44","author":"Fitzsimons","year":"2024","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2025.117662_b9000","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41401-024-01289-6","article-title":"Thermoregulatory pathway underlying the pyrogenic effects of prostaglandin E2 in the lateral parabrachial nucleus of male rats","volume":"45","author":"Xu","year":"2024","journal-title":"Acta Pharmacol Sin."},{"issue":"13","key":"10.1016\/j.bcp.2025.117662_b0145","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.7150\/ijbs.86492","article-title":"The PTGS2\/COX2-PGE2 signaling cascade in inflammation: pro or anti? a case study with type 1 diabetes mellitus","volume":"19","author":"Mart\u00edn-V\u00e1zquez","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.bcp.2025.117662_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110914","article-title":"PGE2-EP2\/EP4 signaling elicits immunosuppression by driving the mregDC-treg axis in inflammatory tumor microenvironment","volume":"39","author":"Thumkeo","year":"2022","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.bcp.2025.117662_b0155","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/eji.202048909","article-title":"Prostaglandin regulation of type 2 inflammation: from basic biology to therapeutic interventions","volume":"51","author":"Oyesola","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2025.117662_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114831","article-title":"A biologically active lipid, thromboxane, as a regulator of angiogenesis and lymphangiogenesis","volume":"163","author":"Majima","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"14","key":"10.1016\/j.bcp.2025.117662_b0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034076","article-title":"Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via changes in Protein Expression during Inflammation","volume":"13","author":"Sherratt","year":"2024","journal-title":"J. Am. Heart Assoc."},{"issue":"8060","key":"10.1016\/j.bcp.2025.117662_b0170","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","article-title":"Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity","volume":"640","author":"Yang","year":"2025","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.bcp.2025.117662_b0175","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1016\/j.cell.2024.07.014","article-title":"Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay","volume":"187","author":"Mihlan","year":"2024","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bcp.2025.117662_b0180","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201910215","article-title":"The LTB4-BLT1 axis regulates actomyosin and \u03b22-integrin dynamics during neutrophil extravasation","volume":"219","author":"Subramanian","year":"2020","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117662_b0185","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41423-020-00559-7","article-title":"Expression of leukotriene B4 receptor 1 defines functionally distinct DCs that control allergic skin inflammation","volume":"18","author":"Koga","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117662_b0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00011-020-01416-z","article-title":"Cysteinyl leukotriene D4 (LTD4) promotes airway epithelial cell inflammation and remodelling","volume":"70","author":"Dholia","year":"2021","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117662_b0195","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2022.08.021","article-title":"Updates on immune mechanisms in aspirin-exacerbated respiratory disease","volume":"151","author":"Laidlaw","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117662_b0200","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/all.15258","article-title":"Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses","volume":"77","author":"Sokolowska","year":"2022","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.bcp.2025.117662_b0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/CH-211346","article-title":"Lipoxins in inflammation","volume":"82","author":"Sachdeva","year":"2022","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"7","key":"10.1016\/j.bcp.2025.117662_b0210","article-title":"Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of","volume":"1866","author":"Al-Shaer","year":"2021","journal-title":"Lipids"},{"key":"10.1016\/j.bcp.2025.117662_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101699","article-title":"Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases","volume":"65","author":"de Gaetano","year":"2023","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117662_b0220","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.orcp.2023.06.001","article-title":"Lipoxins and their relationship with inflammation-associated diseases. a systematic review","volume":"17","author":"Serna","year":"2023","journal-title":"Obes. Res. Clin. Pract."},{"issue":"10","key":"10.1016\/j.bcp.2025.117662_b0225","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/db20-1245","article-title":"Topical Aspirin Administration Improves Cutaneous Wound Healing in Diabetic mice through a Phenotypic Switch of Wound Macrophages Toward an Anti-inflammatory and Proresolutive Profile Characterized by LXA4 Release","volume":"71","author":"Dardenne","year":"2022","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2025.117662_b0230","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13287-021-02141-y","article-title":"Resolvin E1 accelerates pulp repair by regulating inflammation and stimulating dentin regeneration in dental pulp stem cells","volume":"12","author":"Chen","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.bcp.2025.117662_b0235","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117662_b0240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41419-024-06705-7","article-title":"Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice","volume":"15","author":"Grazda","year":"2024","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bcp.2025.117662_b0245","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117662_b0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11033-020-06133-8","article-title":"Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro","volume":"48","author":"Salas-Hern\u00e1ndez","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"9","key":"10.1016\/j.bcp.2025.117662_b0255","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.3390\/ijms23094501","article-title":"Resolution of Inflammation in Retinal Disorders: Briefly the State","volume":"23","author":"Trotta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117662_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115330","article-title":"Protectins: their biosynthesis, metabolism and structure-functions","volume":"206","author":"Vidar Hansen","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"14","key":"10.1016\/j.bcp.2025.117662_b0265","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1111\/febs.16266","article-title":"Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections","volume":"289","author":"Jordan","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2025.117662_b0270","article-title":"Pharmacological effects of specialized pro-resolving mediators in sepsis-induced organ dysfunction: a narrative review","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117662_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106982","article-title":"Lipoxin-mediated signaling: ALX\/FPR2 interaction and beyond","volume":"197","author":"S\u00e1nchez-Garc\u00eda","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117662_b0280","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-pharmtox-051921-085407","article-title":"Lipoxin Mimetics and the Resolution of Inflammation","volume":"63","author":"Godson","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2025.117662_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108439","article-title":"Icosapent ethyl in cardiovascular prevention: Resolution of inflammation through the eicosapentaenoic acid - resolvin E1 - ChemR23 axis","volume":"247","author":"B\u00e4ck","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117662_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101597","article-title":"E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution","volume":"59","author":"Serhan","year":"2022","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117662_b0295","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/cells12010122","article-title":"Anti-Inflammatory effect of Specialized Proresolving Lipid Mediators on Mesenchymal Stem Cells: an In Vitro Study","volume":"12","author":"AlZahrani","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bcp.2025.117662_b0300","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/ijms23031367","article-title":"Maresin-1 and Inflammatory Disease","volume":"23","author":"Saito-Sasaki","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2025.117662_b0305","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bcp.2013.04.019","article-title":"Heterologously expressed formyl peptide receptor 2 (FPR2\/ALX) does not respond to lipoxin a","volume":"85","author":"Hanson","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117662_b0310","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/molpharm.121.000422","article-title":"Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-coupled Receptors","volume":"101","author":"Merlin","year":"2022","journal-title":"Mol. Pharmacol."},{"issue":"41","key":"10.1016\/j.bcp.2025.117662_b0315","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407130121","article-title":"SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor","volume":"121","author":"Alnouri","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bcp.2025.117662_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100705","article-title":"Lipoxin A4 yields an electrophilic 15-oxo metabolite that mediates FPR2 receptor-independent anti-inflammatory signaling","volume":"66","author":"Koudelka","year":"2025","journal-title":"J. Lipid Res."},{"issue":"887","key":"10.1016\/j.bcp.2025.117662_b0325","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adw1245","article-title":"Technical recommendations for analyzing oxylipins by liquid chromatography-mass spectrometry","volume":"18","author":"Schebb","year":"2025","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.bcp.2025.117662_b0330","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/ijms23031308","article-title":"Involvement of Fatty Acids and their Metabolites in the Development of Inflammation in Atherosclerosis","volume":"23","author":"Kotlyarov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117662_b0335","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/ijms24021637","article-title":"Classes of Lipid Mediators and their Effects on Vascular Inflammation in Atherosclerosis","volume":"24","author":"Lubrano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2025.117662_b0340","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.3390\/ijms23094808","article-title":"Molecular Pharmacology of Inflammation Resolution in Atherosclerosis","volume":"23","author":"Kotlyarov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117662_b0345","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.atherosclerosis.2021.03.003","article-title":"Omega-3 fatty acids ameliorate vascular inflammation: a rationale for their atheroprotective effects","volume":"324","author":"Pisaniello","year":"2021","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.bcp.2025.117662_b0350","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00325481.2020.1783937","article-title":"The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention","volume":"133","author":"Trivedi","year":"2021","journal-title":"Postgrad. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117662_b0355","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2020.08.007","article-title":"Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease","volume":"147","author":"Jakiela","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bcp.2025.117662_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580598","article-title":"Could Arachidonic Acid-Derived Pro-Resolving Mediators Be a New Therapeutic Strategy for Asthma Therapy?","volume":"11","author":"Insuela","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117662_b0365","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2147\/COPD.S298678","article-title":"Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD","volume":"16","author":"Celejewska-W\u00f3jcik","year":"2021","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117662_b0370","doi-asserted-by":"crossref","first-page":"162","DOI":"10.55563\/clinexprheumatol\/1jlh15","article-title":"Role of prostaglandins in rheumatoid arthritis","volume":"39","author":"Ma","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bcp.2025.117662_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108455","article-title":"Regulation of inflammation in cancer by dietary eicosanoids","volume":"248","author":"Yang","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2025.117662_b0380","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.ajpath.2022.07.004","article-title":"Resolvin E1 Reduces Tumor Growth in a Xenograft Model of Lung Cancer","volume":"192","author":"Kantarci","year":"2022","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2025.117662_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2024.106944","article-title":"Exploring the unique role of specialized pro-resolving mediators in cancer therapeutics","volume":"178","author":"Quinlivan","year":"2025","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"9","key":"10.1016\/j.bcp.2025.117662_b0390","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/biom13091332","article-title":"Infection, Inflammation, and Immunity in Sepsis","volume":"13","author":"Das","year":"2023","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.bcp.2025.117662_b0395","doi-asserted-by":"crossref","first-page":"e1440","DOI":"10.1002\/ctm2.1440","article-title":"Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsis","volume":"13","author":"Meng","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"18","key":"10.1016\/j.bcp.2025.117662_b0400","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.2174\/0929867327999200917150939","article-title":"Natural COX-2 Inhibitors as Promising Anti-inflammatory Agents: an Update","volume":"28","author":"Cui","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2025.117662_b0405","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41386-022-01527-7","article-title":"Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators","volume":"48","author":"Lamon-Fava","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"19","key":"10.1016\/j.bcp.2025.117662_b0410","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/bph.15919","article-title":"Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35","volume":"179","author":"Qin","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117662_b0415","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/biom12030353","article-title":"Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease","volume":"12","author":"Dalli","year":"2022","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.bcp.2025.117662_b0420","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjp.0701007","article-title":"Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties","volume":"120","author":"Sendobry","year":"1997","journal-title":"Br. J. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500927X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500927X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:15:23Z","timestamp":1781698523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500927X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":85,"alternative-id":["S000629522500927X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117662","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eicosanoids and Inflammation: A delicate balance of Pro-Inflammatory and Pro-Resolving mediators","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117662"}}